Menu
Recruiting NCT03772275

Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure

No phase Interventional Heart Failure

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: New york Heart Association Class II-IV, New york Heart Association Class I.
Who it may be relevant to
Registry conditions: Heart Failure. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Clinical and Economical Study Evaluating the Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure

Overview

Clinical and Economic study of some new biomarkers in chronic heart failure.

Detailed description

The study aimed at evaluation of the clinical and economic value of some new biomarkers in chronic heart failure.

Interventions

  • Diagnostic test New york Heart Association Class II-IV
    New york Heart Association Class II-IV " study of markers"
  • Diagnostic test New york Heart Association Class I
    New york Heart Association Class I

Primary outcome measures

  • Number of participants with elevated markers (IL17) [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • NYHA-Class II-IV

Exclusion criteria

  • Liver or renal dysfunction. --DM

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Diagnostic

Study locations

Egypt · 1 center
  • Sherief Abd-Elsalam — Tanta

Identifiers

NCT: NCT03772275 · Heart failure

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗